Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Flavonoid glycosides has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Rutinosides and other complex glycosides resist human intestinal enzymes and pass to the colon, where bacterial alpha-rhamnosidases and beta-glucosidases release the aglycone for absorption. Whether a person converts a given glycoside at all depends on carrying the right organisms. This is the main reason plasma responses to the same dose vary so widely between people.
Beta-glucosidase and rhamnosidase activity is documented in Lactobacillus plantarum isolates and is used deliberately in fermented food production to shift glycosides toward aglycones. Adding the organism does not guarantee the conversion happens in a given gut. It supplies an enzyme capability that may already be present or absent.
The genus is well described as a source of colonic glycosidase activity acting on dietary polyphenol conjugates. The released aglycone is then either absorbed or broken further by ring fission. The extent varies by strain and by what else is fermenting in the same environment.
The intestinal enzyme lactase phlorizin hydrolase has a second catalytic site that hydrolyses flavonoid glucosides at the brush border, releasing the aglycone for passive diffusion. This is the fast route that glucosides get and rhamnosides do not. It is why a quercetin glucoside appears in plasma within an hour while a rutinoside takes many hours.
Once a flavonoid donates a hydrogen atom it becomes a phenoxyl radical, and ascorbate reduces it back to the parent phenol. The two also co-occur naturally in citrus and berry material. The recycling chemistry is settled; a measured human outcome from the pairing is a separate matter.
Both the glycoside and the released aglycone bind non-heme iron, lowering the fraction of an iron dose available for uptake. Glycosylation reduces but does not remove the chelation because the catechol B ring is usually still free. Spacing a polyphenol-rich product away from an iron dose by two hours is the standard handling.
Fungal enzyme preparations frequently include beta-glucosidase and hemicellulase activity beyond the labelled protease and amylase. That activity can start cleaving flavonoid glycosides before they reach the colon. Whether a specific blend does this depends on the enzyme source and is rarely stated on a label.
Polyphenol-mineral complexation is not selective for iron, so a heavy polyphenol load in the same serving can reduce free calcium and zinc in the lumen. The effect is smaller than for iron and depends on concentration. It matters most at high supplemental amounts taken together.
Nothing specific on file for Flavonoid glycosides. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.